Search for: "Deas v. State"
Results 21 - 40
of 656
Sort by Relevance
|
Sort by Date
31 Jul 2023, 3:12 am
Letter from Congress of the United States, to Robert Patterson, Acting Administrator, DEA (Dec. 21, 2017). [read post]
28 Jul 2023, 11:49 am
The case name is G.P. v. [read post]
13 Jul 2023, 11:13 am
See DEA Diversion Program FAQ. [read post]
11 Jul 2023, 6:39 am
United States) and June 27, 2023 (Counterman v. [read post]
5 Jul 2023, 8:31 am
Some of the most significant updates include the following: Registration Requirements Generally, every practitioner who dispenses, which includes by definition administering and prescribing, controlled substances in schedules II through V, must be registered with DEA. [read post]
30 Jun 2023, 1:14 pm
What happens if a DEA agent has ample evidence of probable cause to search a car, but the New Hampshire police officer whom the DEA agent directs to actually do the search doesn't have that evidence? [read post]
16 Jun 2023, 12:30 pm
In Bostock v. [read post]
14 Jun 2023, 4:55 pm
Burrage v. [read post]
14 Jun 2023, 8:38 am
Walgreens liability depositions taken by Mougey and Gaddy have played in every trial against Walgreens in federal and state court.New Mexico v. [read post]
16 May 2023, 1:41 pm
DEA has seized xylazine and fentanyl mixtures in 48 of 50 States. [read post]
7 May 2023, 6:41 pm
DEA states that it received over 38,000 (yes, 38,000!) [read post]
16 Apr 2023, 7:41 am
This case vividly illustrates the far-reaching divisions among federal and state courts about dealing with Bruton Rule-type cases since the Supreme Court decided Crawford v. [read post]
7 Apr 2023, 6:43 am
Jordan v. [read post]
5 Apr 2023, 4:05 am
In Iowaska Church of Healing v. [read post]
31 Mar 2023, 9:31 am
In response to the PHE, Secretary Azar of the Department of Health and Human Services declared that DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her… [read post]
27 Mar 2023, 10:25 am
The Supreme Court held in Bruton v. [read post]
7 Mar 2023, 7:14 am
Without final DEA rulemaking, at the end of the PHE, federal controlled substance prescribing requirements will revert to their pre-pandemic state. [read post]
2 Mar 2023, 9:05 pm
Supreme Court’s decision in Dobbs v. [read post]
1 Mar 2023, 8:00 am
Without DEA rulemaking, and outside of the PHE, federal prescribing requirements would revert to their pre-pandemic state. [read post]
27 Feb 2023, 3:54 pm
”) The rule would require that the prescriptions be issued consistent with both state and federal law, and the practitioner to maintain an active DEA registration in the state in which the practitioner is located. [read post]
